IRIS
GIACOMETTI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.224
EU - Europa 8.662
AS - Asia 8.339
SA - Sud America 1.915
Continente sconosciuto - Info sul continente non disponibili 459
AF - Africa 445
OC - Oceania 17
Totale 38.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.878
SG - Singapore 2.715
VN - Vietnam 1.702
UA - Ucraina 1.491
RU - Federazione Russa 1.476
BR - Brasile 1.445
CN - Cina 1.319
IT - Italia 1.136
IE - Irlanda 824
DE - Germania 812
SE - Svezia 792
TR - Turchia 727
HK - Hong Kong 717
FR - Francia 578
DK - Danimarca 530
FI - Finlandia 401
KR - Corea 293
GB - Regno Unito 289
CI - Costa d'Avorio 199
AR - Argentina 171
BD - Bangladesh 170
IN - India 168
CA - Canada 132
MX - Messico 127
EC - Ecuador 84
JP - Giappone 72
ZA - Sudafrica 72
NL - Olanda 70
IQ - Iraq 68
ID - Indonesia 63
CO - Colombia 58
MA - Marocco 50
PL - Polonia 49
VE - Venezuela 47
PK - Pakistan 46
PY - Paraguay 37
UZ - Uzbekistan 35
AT - Austria 32
ES - Italia 31
PH - Filippine 29
CL - Cile 28
IR - Iran 27
BE - Belgio 25
TN - Tunisia 24
MY - Malesia 23
PE - Perù 21
EG - Egitto 20
KE - Kenya 20
RO - Romania 18
SA - Arabia Saudita 18
JO - Giordania 17
NP - Nepal 16
RS - Serbia 15
UY - Uruguay 15
AE - Emirati Arabi Uniti 14
DZ - Algeria 14
LT - Lituania 14
OM - Oman 14
CH - Svizzera 13
CR - Costa Rica 13
DO - Repubblica Dominicana 13
KZ - Kazakistan 13
BG - Bulgaria 12
AZ - Azerbaigian 11
EU - Europa 11
JM - Giamaica 11
PS - Palestinian Territory 10
AU - Australia 9
IL - Israele 9
TT - Trinidad e Tobago 9
ET - Etiopia 8
HR - Croazia 8
PA - Panama 8
AL - Albania 7
HN - Honduras 7
SV - El Salvador 7
BO - Bolivia 6
CG - Congo 6
CZ - Repubblica Ceca 6
SN - Senegal 6
TH - Thailandia 6
CY - Cipro 5
GT - Guatemala 5
KW - Kuwait 5
LB - Libano 5
MD - Moldavia 5
NI - Nicaragua 5
TW - Taiwan 5
HU - Ungheria 4
SY - Repubblica araba siriana 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
GR - Grecia 3
LY - Libia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
PT - Portogallo 3
Totale 37.560
Salva come PNG Salva come JPEG
Città #
Ashburn 2.770
Singapore 1.642
Jacksonville 1.481
Chandler 1.156
Fairfield 1.111
Dallas 1.008
Dublin 815
Boardman 742
San Jose 733
Hong Kong 689
Council Bluffs 652
Wilmington 581
Ho Chi Minh City 539
Woodbridge 484
New York 451
Hanoi 436
Seattle 402
Houston 399
Beijing 343
Des Moines 340
Cambridge 332
Ann Arbor 321
Princeton 315
Lawrence 313
San Mateo 309
Moscow 293
Lauterbourg 277
The Dalles 269
Los Angeles 253
Abidjan 199
Hefei 190
San Diego 139
Centro 124
Munich 120
São Paulo 119
Turin 119
Milan 109
Buffalo 105
Da Nang 100
Orem 84
Santa Clara 78
Helsinki 69
London 68
Chicago 66
Turku 59
Guangzhou 56
Redmond 56
Tokyo 55
Haiphong 53
Shanghai 52
Rio de Janeiro 46
Ancona 45
Chennai 45
Miano 45
Norwalk 43
Izmir 41
Mexico City 41
Johannesburg 40
Phoenix 40
Montreal 38
Warsaw 38
Denver 36
Nuremberg 34
Rome 34
Tashkent 34
Atlanta 33
Brooklyn 33
Belo Horizonte 32
Frankfurt am Main 32
Brasília 29
Columbus 29
Guayaquil 29
Washington 29
Wuhan 29
Porto 28
Biên Hòa 25
Dhaka 25
Pune 25
Brussels 24
Manchester 24
Amsterdam 23
Hải Dương 23
Baghdad 22
Curitiba 22
Mumbai 22
Salt Lake City 22
San Francisco 22
Stockholm 22
Falls Church 21
Ninh Bình 21
Ottawa 21
Boston 20
Buenos Aires 20
Can Tho 20
Caracas 20
Poplar 20
Nanjing 19
Wuxi 19
Asunción 18
Elk Grove Village 18
Totale 22.917
Salva come PNG Salva come JPEG
Nome #
Supplementation with tocotrienols from Bixa orellana improves the in vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of infected wound 443
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 335
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 268
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 232
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 214
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 210
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 202
Anticryptosporidial activity of paromomycin. 202
An (Italian) proposal for a comprehensive approach to infections across the surgical pathway 202
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 200
Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study 199
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 191
ACTIVITY OF THE NEW ANTIFUNGAL TRIAZOLE, POSACONAZOLE, AGAINST CRYPTOCOCCUS NEOFORMANS 191
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 187
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 186
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 186
Antimicrobial activity of polycationic peptides 184
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 184
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 180
Ceftazidime-Avibactam for the Treatment of Multidrug-Resistant Pathogens: A Retrospective, Single Center Study 177
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 172
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 167
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 166
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 162
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 162
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 161
SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region 161
Epidemiology and microbiology of surgical wound infections. 159
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 155
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 154
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 153
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 152
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 152
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 152
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 151
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 151
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 150
[Prevalence of Toxocara spp in public playgrounds in a town of Central Italy] 149
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV. 149
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 148
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 148
[Giardiasis: a parasitic disease of continued topicality. Study of prevalence among a selected adult population] 148
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 147
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 145
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 144
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 143
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 143
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 142
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 142
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 141
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 141
OC-34 Clinical outcome of switching to a dual drug regimen (2DR) vs. switching or remaining on a triple (3DR) regimen in the setting of a viral load ≤50 copies/mL 140
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 140
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 140
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 139
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 139
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 138
Tocilizumab in COVID-19 interstitial pneumonia 138
Clinical and microbiological features of ceftolozane/tazobactam-resistant Pseudomonas aeruginosa isolates in a university hospital in central Italy 137
Animal models commonly used to study quorum-sensing inhibitors. 135
In vitro and in vivo effects of sub-MICs of pexiganan and imipenem on Pseudomonas aeruginosa adhesion and biofilm development. 135
Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence 135
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 134
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 134
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 134
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 134
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 133
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 133
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 133
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 133
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy 133
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 132
Anticryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems. 132
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. 131
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 131
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 131
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 130
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 128
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 128
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 128
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 127
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 127
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 127
Antiretroviral therapy management and rationalisation of available resources 127
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 126
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 125
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 125
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 125
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 125
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. 124
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 124
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 124
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50cp/mL. 124
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 123
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 123
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. 123
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 123
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 123
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort. 123
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 123
Totale 15.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.642
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.642
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.289 0 538 25 122 34 173 119 149 167 295 192 475
2022/20233.901 406 364 291 267 282 623 5 204 1.018 20 300 121
2023/20242.261 427 45 136 378 404 463 33 63 16 24 32 240
2024/20254.878 644 417 286 130 165 236 445 186 1.100 299 435 535
2025/202614.004 745 1.118 1.145 1.617 1.268 857 2.479 1.413 1.308 1.151 309 594
2026/20271.383 798 585 0 0 0 0 0 0 0 0 0 0
Totale 38.061